Overcoming the problem of chronic hepatitis B

Despite important advances being made in the treatment of chronic hepatitis B (CHB), complete eradication of hepatitis B virus has remained elusive with the current available therapies. Future treatment for CHB is likely to include drugs with more potent antiviral activity targeting different stages of the viral replication cycle and the host response to CHB. Furthermore, combination therapy might prove to be an important aspect in CHB treatment with the availability of newer drugs.

Section editors:Gary Woodnutt – CovX, San Diego, USA.Paul-Henri Lambert – Centre of Vaccinology, University of Geneva, Switzerland.